Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial

Lancet

Volumn 359, Issue 9323, 2002, Pages 2072-2077

  Chiasson, Jean Louis ^a,g   Josse, Robert G ^b   Gomis, Ramon ^c   Hanefeld, Markolf ^d   Karasik, Avraham ^e   Laakso, Markku ^f  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF BARCELONA   (Spain)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e SHEBA MEDICAL CENTER   (Israel)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; PLACEBO;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ANOREXIA; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPEPSIA; EXERCISE; FEMALE; FLATULENCE; GASTRITIS; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NAUSEA; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DISORDER; ORAL GLUCOSE TOLERANCE TEST; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SKIN DISEASE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; WEIGHT REDUCTION;

EID: 0037097039     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08905-5     Document Type: Article

References (26)

1. Diabetes in America: Epidemiology and scope of the problem
2. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
3. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
4. Insulin secretion and insulin sensitivity in relation to glucose tolerance: Lessons from the Botnia study
5. Metabolic and genetic characterization of prediabetic states: Sequence of events leading to non-insulin-dependent diabetes mellitus
6. Glucose toxicity
7. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance
8. For the STOP-NIDDM trial. An international study on the efficacy of an a-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
9. Diabetes mellitus
10. The natural history of impaired glucose tolerance in the Pima Indians
11. A rapid method for the determination of glycosylated hemoglobin using high pressure liquid chromatography
12. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins
13. 2+ precipitation procedure for quantitation of high-density lipoprotein cholesterol
14. Estimation of concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge
15. Report of the expert committee on the diagnosis and classification of diabetes mellitus
16. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects
17. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives
18. Crucial points at diagnosis: Type 2 diabetes or slow type 1 diabetes
19. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
20. The Da Qing IGT and Diabetes Study: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance
21. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
22. The diabetes prevention program: Headline results
23. Impaired glucose tolerance - Prevalence and conversion to NIDDM
24. Prevalence of diabetes mellitus and impaired glucose tolerance in Aborigines and Chinese in eastern Taiwan
25. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus: A multicenter controlled clinical trial
26. New data on the rate of progression of impaired glucose tolerance to NIDDM and predicting factors